A novel economic framework to assess the cost-effectiveness of bone-forming agents in the prevention of fractures in patients with osteoporosis

SUMMARY: A novel cost-effectiveness model framework was developed to incorporate the elevated fracture risk associated with a recent fracture and to allow sequential osteoporosis therapies to be evaluated. Treating patients with severe osteoporosis after a recent fracture with a bone-forming agent f...

Descripción completa

Detalles Bibliográficos
Autores principales: Söreskog, E., Borgström, F., Lindberg, I., Ström, O., Willems, D., Libanati, C., Kanis, J. A., Stollenwerk, B., Charokopou, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer London 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192365/
https://www.ncbi.nlm.nih.gov/pubmed/33411005
http://dx.doi.org/10.1007/s00198-020-05765-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8192365/
https://www.ncbi.nlm.nih.gov/pubmed/33411005
http://dx.doi.org/10.1007/s00198-020-05765-7

Ejemplares similares